Impact BioMedical Inc. logo

Impact BioMedical Inc.

IBO | AMEX
Chart Builder DCF Calculator
$4.10
+$0.30 (+7.89%)
Nov 2, 2026, 10:31 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Revenue
35K 39K 32K 25K 7K n/a n/a n/a n/a n/a n/a n/a n/a 50K 50K 50K 50K n/a n/a n/a n/a n/a
Cost of Revenue
424K 424K 424K 2K 1K 279K 559K 839K 1.12M 1.12M 1.12M 1.12M 1.12M 1.12M 1.11M 1.11M 1.11M 1.11M 1.11M 835K 556.47K 278.24K
Gross Profit
-389K -385K -392K 23K 6K -279K -559K -839K -1.12M -1.12M -1.12M -1.12M -1.12M -1.07M -1.06M -1.06M -1.06M -1.11M -1.11M -835K -556.47K -278.24K
Operating Income
-5.1M -5.55M -4.27M -29.34M -29.52M -28.99M -28.76M -3.66M -3.61M -4M -4.04M -3.95M -3.76M -3.5M -3.39M -3.42M -3.31M -3.2M -3.19M -2.47M -1.87M -1.47M
Interest Income
13K 14K 12K 12K 12K 12K 12K 12K 12K 12K 12K 12K 12K 99K 192K 271K 324.15K 259.92K 165K 83K 26.85K 1.08K
Pretax Income
-1.8M -15.46M -14.45M -44.21M -38.49M -25.02M -24.74M 1.1M -4.32M -4.56M -4.41M -8.56M -8.36M -8.04M -7.94M -3.64M -3.58M -3.29M -3.24M -2.49M -1.75M -1.47M
Net Income
789K -12.86M -11.84M -44.19M -38.47M -25.02M -24.71M 1.16M -4.25M -4.46M -4.16M -6.45M -7.46M -7.09M -7.1M -3.25M -1.89M -1.49M -1.3M -1.85M -1.17M -993.84K
Selling & General & Admin
2.97M 3.37M 1.98M 2.29M 2.5M 2.17M 1.97M 1.77M 1.61M 1.73M 1.78M 1.62M 1.34M 1.2M 1.1M 1.22M 1.25M 1.08M 992K 815.72K 561.66K 505.9K
Research & Development
284K 283K 340K 122K 152K 77K 157K 728K 885K 1.15M 1.15M 1.21M 1.3M 1.24M 1.23M 1.14M 998.7K 1M 1.08M 817.15K 749.96K 685.64K
Other Expenses
1.46M 1.52M 1.56M 26.95M 26.88M 26.47M 26.07M 326K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
4.71M 5.16M 3.88M 29.37M 29.53M 28.72M 28.2M 2.82M 2.5M 2.88M 2.92M 2.83M 2.64M 2.43M 2.33M 2.36M 2.25M 2.08M 2.07M 1.63M 1.31M 1.19M
Interest Expense
262K 522K 793K 1.06M 1.11M 1.11M 1.07M 921K 718K 573K 444K 648K 638K 661K 693K 486K 572K 433K 300K 178K n/a n/a
Selling & Marketing Expenses
190K 6K 24K 168K 627K 626K 607K 461K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.13M 5.59M 4.3M 29.37M 29.53M 28.99M 28.76M 3.66M 3.61M 4M 4.04M 3.95M 3.76M 3.55M 3.44M 3.47M 3.36M 3.2M 3.19M 2.47M 1.87M 1.47M
Income Tax Expense
-2.58M -2.58M -2.58M 33K 33K 33K 33K n/a n/a n/a n/a -1.88M -621K -621K -621K 91K -1.17M -1.25M -1.4M -310K -309.9K -222.7K
Shares Outstanding (Basic)
8.54M 8.54M 2.5M 965.56K 965.56K 955.84K 911.97K 5.71M 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K
Shares Outstanding (Diluted)
8.54M 8.54M 2.5M 965.56K 965.56K 955.84K 911.97K 5.71M 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K 911.57K
EPS (Basic)
-1.23 -16.04 -17.04 -47.45 -41.27 -27.35 -27.14 1.25 -4.68 -4.91 -4.58 -7.10 -8.24 -7.83 -7.85 -3.59 -2.07 -1.64 -1.43 -2.03 -1.29 -1.09
EPS (Diluted)
-1.23 -16.04 -17.04 -47.45 -45.18 -31.26 -31.06 -2.66 -4.68 -4.91 -4.58 -7.10 -8.24 -7.83 -7.85 -3.59 -2.07 -1.64 -1.43 -2.03 -1.29 -1.09
EBITDA
-401K -13.79M -12.51M -42M -36.25M -22.8M -22.56M 3.13M -2.5M -2.88M -2.92M -2.83M -2.64M -2.38M -2.28M -2.31M -2.2M -2.08M -2.07M -1.63M -1.31M -1.19M
EBIT
-1.54M -14.93M -13.66M -43.14M -37.38M -23.92M -23.68M 2.01M -3.61M -4M -4.04M -3.95M -3.76M -3.5M -3.39M -3.42M -3.31M -3.2M -3.19M -2.47M -1.87M -1.47M
Depreciation & Amortization
1.14M 1.15M 1.15M 1.14M 1.13M 1.12M 1.12M 1.12M 1.12M 1.12M 1.12M 1.12M 1.12M 1.12M 1.11M 1.11M 1.11M 1.11M 1.11M 835K 556.47K 278.24K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.